Heparin and Protein Aggregation
Author Information
Author(s): Vilasi Silvia, Sarcina Rosalba, Maritato Rosa, De Simone Antonella, Irace Gaetano, Sirangelo Ivana
Primary Institution: Dipartimento di Biochimica e Biofisica, Seconda Università degli Studi di Napoli, Naples, Italy
Hypothesis
The study aims to elucidate the molecular mechanism underlying the effect of glycosaminoglycans (GAGs) on amyloid aggregation and related cytotoxicity.
Conclusion
Heparin promotes the formation of harmless amyloid fibrils while also inducing early toxic aggregates in certain proteins.
Supporting Evidence
- Heparin significantly accelerated the aggregation of W7FW14F apomyoglobin.
- The aggregates formed in the presence of heparin were non-toxic to cells.
- Heparin eliminated the lag phase in amyloid fibril formation.
- The study demonstrated that heparin can induce amyloid aggregation in proteins that normally do not aggregate.
Takeaway
Heparin helps proteins form harmless structures instead of toxic ones, which is important for diseases like Alzheimer's.
Methodology
The study used Fourier transform infrared spectroscopy, circular dichroism spectroscopy, electron microscopy, and thioflavin fluorescence dye to examine the effects of heparin on protein aggregation.
Limitations
The study primarily focuses on in vitro conditions, which may not fully replicate in vivo environments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website